Počet záznamů: 1
Therapy for minimal residual tumour disease: beta-galactosylceramide inhibits growth of recurrent HPV16-associated neoplasms after surgery and chemotherapy
SYS 0333598 LBL 02869^^^^^2200385^^^450 005 20240103192517.6 014 $a 000277551100025 $2 WOS 017 $a 10.1002/ijc.24887 $2 DOI 100 $a 20110225d m y slo 03 ba 101 0-
$a eng 102 $a DE 200 1-
$a Therapy for minimal residual tumour disease: beta-galactosylceramide inhibits growth of recurrent HPV16-associated neoplasms after surgery and chemotherapy 215 $a 2 s. 463 -1
$1 001 cav_un_epca*0256782 $1 011 $a 0020-7136 $e 1097-0215 $1 200 1 $a International Journal of Cancer $v Roč. 126, č. 12 (2010), s. 2997-3004 $1 210 $c Wiley 610 0-
$a beta-galactosylceramide 610 0-
$a tumour immunotherapy 610 0-
$a NKT cells 700 -1
$3 cav_un_auth*0105504 $a Šímová $b Jana $p UMG-J $w Laboratory of Transgenic Models of Diseases $4 070 $T Ústav molekulární genetiky AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0105388 $a Indrová $b Marie $p UMG-J $w Laboratory of Transgenic Models of Diseases $4 070 $T Ústav molekulární genetiky AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0105320 $a Bieblová $b Jana $p UMG-J $w Laboratory of Transgenic Models of Diseases $4 070 $T Ústav molekulární genetiky AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0105451 $a Mikyšková $b Romana $p UMG-J $w Laboratory of Transgenic Models of Diseases $4 070 $T Ústav molekulární genetiky AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0105331 $a Bubeník $b Jan $p UMG-J $4 070 $T Ústav molekulární genetiky AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0105479 $a Reiniš $b Milan $p UMG-J $w Laboratory of Transgenic Models of Diseases $4 070 $T Ústav molekulární genetiky AV ČR, v. v. i.
Počet záznamů: 1